Oasi Research Institute - IRCCS, Troina, Italy.
J Parkinsons Dis. 2019;9(1):203-206. doi: 10.3233/JPD-171292.
Technological innovation related to the advent and development of the Next-Generation Sequencing (NGS) has provided significant advances in the diagnosis of disorders with genetic and phenotypic variability, such as neurodegenerative diseases. However, the interpretation of NGS data often remains challenging, although advanced prediction tools have contributed to primarily assess the impact of some missense variants. Here, we report a patient with Parkinson's disease (PD) and a family history of disease, in which a panel of 29 disease-causing or risk genes for PD were analyzed. We identified a new missense variant in the SNCA gene. Although this variant might be associated with PD in this family, it has been currently classified as a "Variant of Unknown Significance" because of the lack of segregation with disease. Indeed, we subsequently found the same mutation in an unaffected sister. Nevertheless, this finding may help clinicians and researchers in questioning the causative role of genetic variants within the daily clinical and diagnostic settings.
技术创新与下一代测序(NGS)的出现和发展相关,为具有遗传和表型变异性的疾病(如神经退行性疾病)的诊断提供了重大进展。然而,尽管先进的预测工具有助于主要评估某些错义变异的影响,但 NGS 数据的解释仍然具有挑战性。在这里,我们报告了一名患有帕金森病(PD)且有家族病史的患者,对 29 个导致 PD 的致病或风险基因进行了分析。我们在 SNCA 基因中发现了一个新的错义变异。虽然该变异可能与该家族的 PD 相关,但由于与疾病无分离,目前被归类为“意义不明的变异”。事实上,我们随后在一个未受影响的姐姐中发现了相同的突变。然而,这一发现可能有助于临床医生和研究人员在日常临床和诊断环境中质疑遗传变异的因果作用。